Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.87
Price to sales ratio

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4383
RNAZ
TransCode Therapeutics, Inc. - Common Stock
2.18 USD-4.39%-24.57%-56.92%-77.07%36.91 M USD
4390
OABIW
OmniAb, Inc. - Warrant
0.2500 USD0.00%+6.88%+454.32%+80.51%36.35 M USD
4410
QNCX
Quince Therapeutics, Inc. - Common Stock
33.75 USD+3.85%+2.27%+54.75%+1970.55%34.33 M USD
4418
LITS
Lite Strategy, Inc. - Common Stock
0.98 USD-2.00%-4.85%+3.16%-67.11%33.34 M USD

Frequently asked questions about Context Therapeutics Inc. Common Stock

What is the Context Therapeutics Inc. Common Stock stock price today?

The current price of Context Therapeutics Inc. Common Stock (CNTX) is 0.38. Over the past 24 hours, the stock has changed by -9.52%. Follow the CNTX chart for real-time price dynamics.

What is the stock ticker of Context Therapeutics Inc. Common Stock?

Context Therapeutics Inc. Common Stock trades under the ticker CNTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Context Therapeutics Inc. Common Stock stock going up?

CNTX has changed by -22.45% over the last week, -38.71% over the last month, and -55.29% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Context Therapeutics Inc. Common Stock?

Context Therapeutics Inc. Common Stock currently has a market capitalization of 34.91 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Context Therapeutics Inc. Common Stock earnings last quarter?

Last quarter, Context Therapeutics Inc. Common Stock reported earnings of -0.15 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Context Therapeutics Inc. Common Stock net income for the last quarter?

Context Therapeutics Inc. Common Stock reported net income of -14.56 M for the last quarter. The previous quarter showed -8.68 M, which means net income changed by -67.71%.

How many employees does Context Therapeutics Inc. Common Stock have?

As of the latest available data, Context Therapeutics Inc. Common Stock has 15 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Context Therapeutics Inc. Common Stock stock?

You can buy Context Therapeutics Inc. Common Stock (CNTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Context Therapeutics Inc. Common Stock stock?

Investing in Context Therapeutics Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CNTX chart and related analysis on metatrader.com as part of your research.

News